Found: 38
Select item for more details and to access through your institution.
The first European interdisciplinary Ewing sarcoma research summit.
- Published in:
- 2012
- By:
- Publication type:
- Proceeding
Pediatric soft tissue sarcomas.
- Published in:
- CA: A Cancer Journal for Clinicians, 1994, v. 44, n. 4, p. 211, doi. 10.3322/canjclin.44.4.211
- By:
- Publication type:
- Article
Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis.
- Published in:
- Nature Medicine, 2002, v. 8, n. 11, p. 1276, doi. 10.1038/nm787
- By:
- Publication type:
- Article
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R.
- Published in:
- International Journal of Cancer, 1998, v. 76, n. 2, p. 223, doi. 10.1002/(SICI)1097-0215(19980413)76:2<223::AID-IJC9>3.0.CO;2-Z
- By:
- Publication type:
- Article
Suppression of rhabdomyosarcoma growth by fumagillin analog TNP-470.
- Published in:
- International Journal of Cancer, 1996, v. 68, n. 5, p. 596, doi. 10.1002/(SICI)1097-0215(19961127)68:5<596::AID-IJC7>3.0.CO;2-U
- By:
- Publication type:
- Article
Chromogranin-a expression in gastric and colon cancer tissues.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 2, p. 189, doi. 10.1002/ijc.2910510205
- By:
- Publication type:
- Article
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation.
- Published in:
- Nature Medicine, 2007, v. 13, n. 12, p. 1504, doi. 10.1038/nm1686
- By:
- Publication type:
- Article
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells.
- Published in:
- Nature Medicine, 2005, v. 11, n. 11, p. 1238, doi. 10.1038/nm1312
- By:
- Publication type:
- Article
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
- Published in:
- Nature Medicine, 2004, v. 10, n. 2, p. 182, doi. 10.1038/nm982
- By:
- Publication type:
- Article
1α,25-Dihydroxy-16-Ene-23-Yne-26,27- Hexafluorocholecalciferol (Ro24-5531) Modulation of Insulin-Like Growth Factor-Binding Protein-3 and Induction of Differentiation and Growth Arrest in a Human Osteosarcoma Cell Line.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 1, p. 93, doi. 10.1210/jc.81.1.93
- By:
- Publication type:
- Article
Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.
- Published in:
- Oncogene, 2003, v. 22, n. 50, p. 8205, doi. 10.1038/sj.onc.1206878
- By:
- Publication type:
- Article
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).
- Published in:
- Sarcoma, 2019, p. 1, doi. 10.1155/2019/7656747
- By:
- Publication type:
- Article
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.
- Published in:
- Sarcoma, 2017, p. 1, doi. 10.1155/2017/8685638
- By:
- Publication type:
- Article
Low dose histone deacetylase inhibitor, depsipeptide (FR901228), promotes adenoviral transduction in human rhabdomyosarcoma cell lines.
- Published in:
- Sarcoma, 2004, v. 8, n. 1, p. 25, doi. 10.1080/13577140410001679220
- By:
- Publication type:
- Article
Autocrine transforming growth factor-β growth pathway in murine osteosarcoma cell lines associated with inability to affect phosphorylation of retinoblastoma protein.
- Published in:
- Sarcoma, 2000, v. 4, n. 3, p. 93, doi. 10.1080/13577140020008057
- By:
- Publication type:
- Article
Molecular alterations in pediatric sarcomas: potential targets for immunotherapy.
- Published in:
- Sarcoma, 1998, v. 2, n. 2, p. 77, doi. 10.1080/13577149878037
- By:
- Publication type:
- Article
Disruption of the MyoD/p21 pathway in rhabdomyosarcoma.
- Published in:
- Sarcoma, 1997, v. 1, n. 3/4, p. 135, doi. 10.1080/13577149778218
- By:
- Publication type:
- Article
Rhabdomyosarcoma – working out the pathways.
- Published in:
- Oncogene, 1999, v. 18, n. 38, p. 5340, doi. 10.1038/sj.onc.1203038
- By:
- Publication type:
- Article
AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma.
- Published in:
- Oncogene, 1998, v. 17, n. 10, p. 1261, doi. 10.1038/sj.onc.1202050
- By:
- Publication type:
- Article
Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology.
- Published in:
- 2016
- By:
- Publication type:
- Proceeding
Response to Early Treatment Evaluated with <sup>18</sup>F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 735, doi. 10.2967/jnumed.115.162412
- By:
- Publication type:
- Article
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript.
- Published in:
- 2017
- By:
- Publication type:
- journal article
LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Insights into pediatric rhabdomyosarcoma research: Challenges and goals.
- Published in:
- 2019
- By:
- Publication type:
- journal article
p53 Regulates Human Insulin-Like Growth Factor II Gene Expression through Active P4 Promoter in Rhabdomyosarcoma Cells.
- Published in:
- DNA & Cell Biology, 1998, v. 17, n. 2, p. 125, doi. 10.1089/dna.1998.17.125
- By:
- Publication type:
- Article
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 16, p. 2448, doi. 10.1002/cncr.28728
- By:
- Publication type:
- Article
Effectiveness of chemotherapy in non-rhabdomyosarcoma soft tissue sarcomas-response.
- Published in:
- Pediatric Blood & Cancer, 2005, v. 45, n. 2, p. 228, doi. 10.1002/pbc.20393
- By:
- Publication type:
- Article
Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: The national cancer institute experience.
- Published in:
- Pediatric Blood & Cancer, 2005, v. 44, n. 5, p. 449, doi. 10.1002/pbc.20262
- By:
- Publication type:
- Article
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 Mutation.
- Published in:
- Human Mutation, 2005, v. 26, n. 2, p. 94, doi. 10.1002/humu.20192
- By:
- Publication type:
- Article
Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003.
- Published in:
- Oncologist, 2012, v. 17, n. 3, p. 321, doi. 10.1634/theoncologist.2010-0265
- By:
- Publication type:
- Article
The Role of IGF-1R in Pediatric Malignancies.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 83, doi. 10.1634/theoncologist.2008-0189
- By:
- Publication type:
- Article
The Biology Behind mTOR Inhibition in Sarcoma.
- Published in:
- Oncologist, 2007, v. 12, n. 8, p. 1007, doi. 10.1634/theoncologist.12-8-1007
- By:
- Publication type:
- Article
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 8, p. 1301, doi. 10.1002/cncr.33349
- By:
- Publication type:
- Article
Mechanisms of sarcoma development.
- Published in:
- Nature Reviews Cancer, 2003, v. 3, n. 9, p. 685, doi. 10.1038/nrc1168
- By:
- Publication type:
- Article
Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 12, p. 962, doi. 10.1093/jnci/djr156
- By:
- Publication type:
- Article
Progress in the Curative Treatment of Childhood Hematologic Malignancies.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth.
- Published in:
- Oncogenesis, 2019, v. 8, n. 3, p. 1, doi. 10.1038/s41389-019-0129-z
- By:
- Publication type:
- Article